EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Incorporating estimands into meta-analyses of clinical trials

Antonio Remiro-Azócar iD, Pepa Polavieja, Emmanuelle Boutmy iD, Alessandro Ghiretti, Lise Lotte Nystrup Husemoen, Khadija Rerhou Rantell, Tatsiana Vaitsiakhovich, David M Phillippo iD, Jay J H Park, Helle Lynggaard iD, Robert Bauer iD, Antonia Morga

Research Synthesis Methods · 30.07.2026 · 1-28

DOI: 10.1017/rsm.2026.10107 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Research Synthesis Methods, online erschienen am 30.07.2026. Verfasst von Antonio Remiro-Azócar und 11 weiteren Autor:innen. Beteiligte Einrichtung: External Collaboration and Experimentation, Novo Nordisk, Madrid, Spain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The estimand framework is increasingly established to pose research questions in confirmatory clinical trials. In evidence synthesis, the uptake of estimands has been modest, and the population, intervention, comparator, and outcome (PICO) framework is more often applied. While PICOs and estimands have overlapping elements, the estimand framework explicitly considers different strategies for intercurrent events. We propose a pragmatic framework for the use of estimands in meta-analyses of clinical trials, highlighting the value of estimands to systematically identify and mitigate key sources of quantitative heterogeneity, and to enhance the applicability or external validity of pooled estimates. Focus is placed on the role of strategies for intercurrent events, within the specific context of meta-analyses for health technology assessment. We apply the estimand framework to a network meta-analysis of clinical trials, comparing the efficacy of semaglutide versus dulaglutide in type 2 diabetes. We explore the impact of a treatment policy strategy for treatment discontinuation or initiation of rescue medication versus a hypothetical strategy for the corresponding intercurrent events. The specification of different target estimands at the meta-analytical level allows us to be explicit about the source of heterogeneity, the intercurrent event strategy, driving any potential differences in results. We advocate for the integration of estimands into the planning of meta-analyses, while acknowledging that potential challenges exist in the absence of subject-level data. Estimands can complement PICOs to strengthen communication between stakeholders about what evidence syntheses seek to demonstrate, and to ensure that the generated evidence is maximally relevant to healthcare decision-makers.

Schlagwörter

Stichwörter der Autor:innen

estimandshealth technology assessmentindirect treatment comparisonmeta-analysisnetwork meta-analysisscientific reasoning

Autor:innen und Institutionen

  • External Collaboration and Experimentation, Novo Nordisk, Madrid, Spain.
  • Cross-Trial Evidence and Health Technology Assessment, Novo Nordisk Pharma, Madrid, Spain.
  • Global Epidemiology, Merck Group, Germany.
  • Data and Statistical Sciences Centre for RWE and EG, Daiichi Sankyo Europe GmbH, Germany.
  • Real-World Evidence, Novo Nordisk A/S, Denmark.
  • Regulatory Affairs, MHRA, UK.

ORCID-Profile: Antonio Remiro-Azócar, Emmanuelle Boutmy, David M Phillippo, Helle Lynggaard, Robert Bauer

Förderung

  • Medical Research Council

Zitieren

APA

Remiro-Azócar, A., Polavieja, P., Boutmy, E., Ghiretti, A., Husemoen, L. L. N., Rantell, K. R., Vaitsiakhovich, T., Phillippo, D. M., Park, J. J. H., Lynggaard, H., Bauer, R., & Morga, A. (2026). Incorporating estimands into meta-analyses of clinical trials. Research Synthesis Methods, 1-28. https://doi.org/10.1017/rsm.2026.10107

Vancouver

Remiro-Azócar A, Polavieja P, Boutmy E, Ghiretti A, Husemoen LLN, Rantell KR, et al. Incorporating estimands into meta-analyses of clinical trials. Research Synthesis Methods. 2026:1-28. doi:10.1017/rsm.2026.10107

BibTeX
@article{RemiroAzcar2026,
  author = {Remiro-Azócar, Antonio and Polavieja, Pepa and Boutmy, Emmanuelle and Ghiretti, Alessandro and Husemoen, Lise Lotte Nystrup and Rantell, Khadija Rerhou and Vaitsiakhovich, Tatsiana and Phillippo, David M and Park, Jay J H and Lynggaard, Helle and Bauer, Robert and Morga, Antonia},
  title = {Incorporating estimands into meta-analyses of clinical trials},
  journal = {Research Synthesis Methods},
  year = {2026},
  pages = {1--28},
  doi = {10.1017/rsm.2026.10107}
}
Kostenlos starten →